Usefulness of 6-minute walk test, plasma neurohumoral and cytokine activation in the assessment of symptomatic patients with left ventricle dysfunction caused by chronic severe mitral valve regurgitation
暂无分享,去创建一个
J. Korewicki | T. Rywik | W. Piotrowski | A. Biederman | J. Janas | P. Leszek | A. Klisiewicz | Przemys¥aw Leszek
[1] B. Keevil,et al. Utility of plasma N-terminal brain natriuretic peptide as a marker of functional capacity in patients with chronic severe mitral regurgitation. , 2006, The American journal of cardiology.
[2] M. Enriquez-Sarano,et al. B-Type Natriuretic Peptide in Organic Mitral Regurgitation: Determinants and Impact on Outcome , 2005, Circulation.
[3] S. Aydoǧdu,et al. Plasma brain natriuretic peptide levels in patients with rheumatic heart disease , 2004, European journal of heart failure.
[4] Masazumi Watanabe,et al. Is measurement of plasma brain natriuretic peptide levels a useful test to detect for surgical timing of valve disease? , 2004, International journal of cardiology.
[5] S. Murphy,et al. Comparison of B-type natriuretic peptide levels in patients with heart failure with versus without mitral regurgitation. , 2004, American Journal of Cardiology.
[6] H. Oral,et al. Changes in systemic sympathetic nervous system activity after mitral valve surgery and their relationship to changes in left ventricular size and systolic performance in patients with mitral regurgitation. , 2004, American heart journal.
[7] J. Korewicki,et al. Mitral valve regurgitation and plasma neurohumoral and cytokine activation. , 2004, Acta cardiologica.
[8] R. Razzolini,et al. Plasma levels of tumor necrosis factor-alpha correlate with the six-minute walk test results in patients with mild to moderate heart failure. , 2004, Italian heart journal : official journal of the Italian Federation of Cardiology.
[9] B. Carabello. Indications for mitral valve surgery. , 2004, The Journal of cardiovascular surgery.
[10] A. Kerr,et al. Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. , 2003, Journal of the American College of Cardiology.
[11] H. Oral,et al. Compared with control subjects, the systemic sympathetic nervous system is activated in patients with mitral regurgitation. , 2003, American heart journal.
[12] M. Desnos,et al. Bedside B‐type natriuretic peptide and functional capacity in chronic heart failure , 2003, European journal of heart failure.
[13] S. Bolling,et al. Myocardial Proinflammatory Cytokine Expression and Left Ventricular Remodeling in Patients With Chronic Mitral Regurgitation , 2003, Circulation.
[14] B. Carabello. The Ten Most Commonly Asked Questions About Mitral Regurgitation , 2002, Cardiology in review.
[15] Y. Yazaki,et al. Measurement of plasma brain natriuretic peptide level as a guide for cardiac overload. , 2001, Cardiovascular research.
[16] M. J. Smith,et al. Relation of systemic sympathetic nervous system activation to echocardiographic left ventricular size and performance and its implications in patients with mitral regurgitation. , 2000, The American journal of cardiology.
[17] P. De Groote,et al. Effect of mitral valve surgery on exercise capacity, ventricular ejection fraction and neurohormonal activation in patients with severe mitral regurgitation. , 2000, Journal of the American College of Cardiology.
[18] J. Thomas,et al. Elevated circulating levels of serum tumor necrosis factor-alpha in patients with hemodynamically significant pressure and volume overload. , 2000, Journal of the American College of Cardiology.
[19] B. Carabello,et al. Chronic mitral regurgitation: when and how to operate. , 1998, Chest.
[20] Y. Kihara,et al. Marked elevation of brain natriuretic peptide levels in pericardial fluid is closely associated with left ventricular dysfunction. , 1998, Journal of the American College of Cardiology.
[21] N. Moat,et al. Plasma brain natriuretic peptide concentrations in patients with chronic mitral regurgitation. , 1997, The Journal of heart valve disease.
[22] H. Oral,et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). , 1996, Journal of the American College of Cardiology.
[23] N. Dzimiri,et al. Comparison of the effect of left ventricular volume and pressure overload on beta-adrenoceptor density in left heart valvular disease. , 1996, International journal of cardiology.
[24] D. Mann,et al. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. , 1996, Circulation.